| Erika Hartsock, PHARMD | |
|
669 Agency Main St, Harlem, MT 59526-9455 | |
| (406) 353-3104 | |
| Not Available |
| Full Name | Erika Hartsock |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 669 Agency Main St, Harlem, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598465767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PHA-PHA-LIC-83856 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erika Hartsock, PHARMD 519 Hinsdale Rd N, Hinsdale, MT 59241-8500 Ph: (406) 263-4566 | Erika Hartsock, PHARMD 669 Agency Main St, Harlem, MT 59526-9455 Ph: (406) 353-3104 |
News Archive
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, is presenting a scientific poster today at the Multinational Association of Supportive Care in Cancer Conference in Vancouver, B.C. The poster presentation, co-authored by Dr. David Nowotnik of Access Pharmaceuticals and Dr. Caroline Dumas of SpePharm Holdings, summarizes MuGard clinical experience from cancer patients globally undergoing radiotherapy and/or chemotherapy.
Trusts are far better prepared to deal with patients injured in chemical incidents following national training but the design and distribution of chemical protective suits and shelters are still a problem, says research published this week in Emergency Medicine Journal.
In physical, biological and technological systems, the time that a system's components take to influence each other can affect the transition to synchronization, an important finding that improves understanding of how these systems function, according to a study led by Georgia State University.
pSivida Corp., a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that its licensee Alimera Sciences, Inc. reported the submission of its response to the second Complete Response Letter from the U.S. Food and Drug Administration with respect to ILUVIEN for chronic diabetic macular edema.
› Verified 8 days ago
Sally Ann Wilhelm, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 456 Gros Ventre Ave, Harlem, MT 59526 Phone: 406-353-3104 | |
Hilary Ann Krass-richman, PHARM, D., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42465 Us Highway 2, Harlem, MT 59526 Phone: 406-353-3535 Fax: 406-353-2727 | |
Dr. Joel Bradford Hinckley, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 669 Agency Main St, Pharmacy Department, Harlem, MT 59526 Phone: 406-353-3103 Fax: 406-353-3266 | |
Shirley Pattison Baumgartner, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Rr 1 Box 67, Harlem, MT 59526 Phone: 406-353-3263 Fax: 406-353-3266 | |
Brooke Elizabeth Leonard, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 669 Agency Main St, Harlem, MT 59526 Phone: 406-353-3100 | |
Susan Irene Hayes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 669 Agency Main St, Harlem, MT 59526 Phone: 406-353-3114 |